Synergy Between Cephalosporin and Aminoglycoside
|
|
- Sybil Baldwin
- 5 years ago
- Views:
Transcription
1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1974, P Copyright American Society for Microbiology Vol. 5, No. 6 Printed in U.S.A. Synergy Between Cephalosporin and Aminoglycoside Antibiotics Against Providencia and Proteus PHINEAS J. HYAMS, MICHAEL S. SIMBERKOFF, AND JAMES J. RAHAL, JR. Infectious Disease Division, New York Veterans Administration Hospital and Department of Medicine, New York University School of Medicine, New York, New York Received for publication 14 January 1974 Clinical isolates of Providencia and Proteus with relative aminoglycoside resistance were tested for susceptibility to combinations of gentamicin or tobramycin with cephalothin or cefazolin. The minimal bactericidal concentration of aminoglycoside for one-third of the strains was reduced by fourfold or more in the presence of one-fourth of the minimal bactericidal concentration of either cephalosporin. This effect was achieved by clinically attainable concentrations of cephalothin or cefazolin. Although Providencia has been an uncommon cause of clinical infections, recent epidemics have been described in hospitalized patients, particularly in burn units (5, 14, 15). We have noted a gradually increasing incidence of clinical isolates of Providencia in our hospital, although serious infections have remained rare. In vitro studies on these strains have indicated relative resistance to all aminoglycoside antibiotics. Most strains have required minimal inhibitory and bactericidal concentrations of 12.5 to 50 gg of gentamicin per ml. A synergistic effect of penicillins or cephalosporins with aminoglycosides has previously been demonstrated against Enterobacteriaceae (3, 4, 10) and Pseudomonas (6, 12, 17). We have therefore studied nine strains of Providencia and seven strains of the related genus, Proteus, which were moderately or highly resistant to gentamicin. Our purpose was to evaluate two cephalosporins, cephalothin and cefazolin, in crossover combination with two aminoglycosides, gentamicin and tobramycin, for possible in vitro synergy against these organisms. MATERIALS AND METHODS Providencia and Proteus strains were collected from the clinical microbiology laboratory on the basis of gentamicin resistance by routine disk sensitivity testing. Tube dilution assays were done in Mueller- Hinton broth as previously described (9). Grid studies were performed so that double dilutions of cephalothin, and cefazolin were combined with double dilutions of gentamicin or tobramycin. This resulted in duplicate minimal inhibitory and bactericidal concentration values for each drug against each strain. Of the 144 such duplications, four differed by two tube dilutions and the remainder differed by one dilution or less. Synergy was defined as a fourfold decline in minimal inhibitory concentrations (MIC) or minimal bactericidal concentration (MBC) of gentamicin or tobramycin after the addition of one-fourth of the MIC or MBC of a cephalosporin antibiotic to each tube. 571 RESULTS The MIC and MBC values of each drug against the nine strains of Providencia and seven strains of Proteus tested are shown in Fig. 1 to 4. Eight of nine Providencia strains were resistant to clinically attainable concentrations of either cephalothin or cefazolin. One was inhibited by 62 sg/ml but required >500 gg/ ml for a bactericidal effect. Three strains were inhibited by 3.1 gg of tobramycin per ml and one by that concentration of gentamicin. However, the MIC and MBC of either drug against most Providencia was 12.5 to 50,g/ml. All seven Proteus strains studied were indole positive and highly resistant to cephalosporins. Unlike Providencia, however, a clear difference in sensitivity to gentamicin and tobramycin existed in four of the seven isolates. Two strains of Proteus morganii and two of Proteus vulgaris were sensitive to tobramycin and relatively resistant to gentamicin. Two strains of Proteus rettgeri were resistant to both aminoglycosides, and another Proteus morganii isolate was highly resistant to all antibiotics. Figure 1 indicates the effect of cephalothin and cefazolin on the MICs of tobramycin and gentamicin against Providencia. Ninety-one percent of Providencia strains were susceptible to a synergistic effect, demonstrated by a fourfold decline in the MIC of tobramycin or gen-
2 572 HYAMS, SIMBERKOFF, AND RAHAL ANTIMICROB. AG. CHEMOTHER. E 50,0 _ G + c z PROVIDENCIA - MIC G + C F Z 3. _ ugdmdof CZ ) ) ) )5 MIC of CZ log/mi) Bacterioa A 8 C 0 E F 6 H Strain E > 50.0 T+CZ fh AA addedlaocf 0 ) ) (lag/rni)) (IC9of CF BDoctrio Strain A C 0 E F C H _ T + C F 0 cr_ti InE0n11 L 11 9ug/rnotfCZ 0 )5 0 )5 0 ) )5 0 )5 0 ) lg/mnioftc F ) added too added toot IC/ofnC) N)IC at CF Bacter ia) Doctoria) Strain A B C D E F 6 H Strain A B C D E F C H tamicin. This usually required less than 62,ug of cephalosporin per ml, a clinically attainable level of either cephalothin or cefazolin. Figure 2 shows the effect of each combination of antibiotics on the MBC of Providencia strains. A synergistic effect occurred in 89% of the tests, but in several instances 125 to 250,g of a cephalosporin per ml was required. The results of studies carried out with Proteus species are presented in Fig. 3 and 4. Tests for synergy involving tobramycin were not done with four of the seven strains since they were highly sensitive to this antibiotic. Of all tests carried out, a fourfold decline in MIC occurred in 75% and usually required 15 to 62,ug of a cephalosporin per ml (Fig. 3). Figure 4 shows that only 65% of Proteus strains were susceptible to a synergistic effect on the MBC of aminoglycosides and approximately half of these required greater than 62 usg of a cephalosporin per ml to achieve this result. FIG. 1. Effect of cephalothin (CF) and cefazolin (CZ) on the MIC of gentamicin (G) and tobramycin (7) against Providencia. The left bar of each pair indicates the MIC of tobramycin or gentamicin in the absence of added cephalosporin. The right bar shows the MIC of the aminoglycoside in the presence of one-fourth or less of the MIC of either cephalothin or cefazolin. Table 1 summarizes the percent of cephalosporin-aminoglycoside combinations which produced synergy against Providencia and Proteus. Providencia were somewhat more susceptible than Proteus to the combinations tested. The difference in effect on MBC (but not MIC) was significant with a P value of <0.05. If only those strains susceptible to synergy with the use of 62,gg/ml or less of either cephalosporin are considered, a significantly greater number of Providencia strains showed fourfold lower MICs. However, the synergistic effect on MBCs occurred in an equal percentage of Providencia and Proteus isolates (36 and 37%, respectively). Thus, a clinically attainable serum concentration of cephalosporin favorably effected the bactericidal activity of tobramycin and gentamicin in approximately one-third of these relatively resistant organisms. The more highly resistant organisms (those with MBCs of 25 50,ug/ml) were usually susceptible to a synergistic
3 VOL. 5, 1974 CEPHALOSPORIN-AMINOGLYCOSIDE SYNERGY 573 PROVIDENCIA - MBC >',0.S Ii-,I G + C Z G + CF 3.1 QC) ioq lmi lofc IS IIS /l eofcf added to > >dd5 ftc NBC of CZ 500 >500 > >500 >500 >500 > NBC of C F >500 >500 >500 >500 lag/all Cq /0If BoSteraio A B C 0 E F G H Decteriel A B C D E St rolo E >50.0- LA. 00 T+CZ T+ CF 49/l oftcz o g/iloft CF 0O N(BCo/f CZl 500 >500 >500 >500 >500 >500 >250 >500 >500 18C/of > >500 *500 >500 >250 > BaSterail B C D E F G B cterial A B C D E F G H FIG. 2. Effect of cephalothin (CF) and cefazolin (CZ) on the MBC of gentamicin (G) and tobramycin (7) against Providencia. The left bar of each pair indicates the MBC of tobramycin or gentamicin in the absence of added cephalosporin. The right bar shows the MBC of the aminoglycoside in the presence of one-fourth or less of the MBC of either cephalothin or cefazolin. effect on MIC values, but not on MBCs. In three instances (1.6% of tests performed), the addition of 15 ug of cephalothin per ml to either gentamicin or tobramycin resulted in an antagonistic effect on the MBC only. The incidence of synergy associated with each of the four antibiotics studied is presented in Table 2. Synergy occurred in 75% of tests performed with cephalothin and in 93% tested with cefazolin, as determined by MIC. The difference in effect on MBCs was less pronounced. If synergy by 62,ug/ml or less was considered alone, cefazolin was again more active than cephalothin although at a slightly lower than 95% probability level (0.1 > P > 0.05). DISCUSSION The results of this study indicate that the MIC and MBC of either gentamicin or tobramycin for relatively resistant Providencia or Proteus isolates may be significantly reduced by the addition of cephalothin or cefazolin. Although a bacteriostatic effect is produced by this combination of antibiotics in 60 to 80% of instances, bactericidal activity occurs in only 36 to 37%. Further, when the MBC of gentamicin or tobramycin for a particular strain is 25 /g/ml or greater, a synergistic effect is unlikely to result from clinically attainable concentrations of cephalothin or cefazolin. Nevertheless, since the MIC of gentamicin for a large proportion of Providencia strains tested in our laboratory is 12.5,ug/ml or more, the additional use of a cephalosporin antibiotic may be clinically useful. Cefazolin is slightly more active against Providencia and Proteus than cephalothin, and higher blood levels are attained by usual doses. Our data showed no evident differences in synergistic effect between tobramycin and gentamicin when combined with cephalosporins. Four strains of indole-positive Proteus were c H
4 574 HYAMS, SIMBERKOFF, AND RAHAL ANTIMICROB. AG. CHEMOTHER. E>500 o 500 C-!, gu 24 1 G+CZ a/e;co l ItO CZ ? 500 Bocteriul StrmiR > 500 z 50.0 z? 12.4 m 3'1 LA- O.78 --' <39 ae - j N T+ CZ g/lmlaof CZ 0 MIC of CZ (A g/ml) 250 Bacterial Strain I L N K I PROTEUS- M C p lig/o; f CF o Idded t 2 NIC of CF > > 500 >500 ag/im) lecterisi Stroll J K N I 0 P T+CF Ag/mlato Cf NBCatoft > >500 >500 FIG. 3. Effect of cephalothin (CF) and cefazolin (CZ) on the MIC of gentamicin (G) and tobramycin (T) against Proteus. The left bar of each pair indicates the MIC of tobramycin or gentamicin in the absence of added cephalosporin. The right bar shows the MIC of the aminoglycoside in the presence of one-fourth or less of the MIC of either cephalothin or cefazolin. Bacterial Strain G+CF 0 P
5 VOL. 5, 1974 CEPHALOSPORIN-AMINOGLYCOSIDE SYNERGY 575 >> G +CZ PROTEUS-MBC Go+CF B 3.1 <.39 oail/mliofcz aodded to G NBCgomi) >500 >500 > > > 500 Bocter ioi Stroin -E>50.0- ~'50.0- ~?12.4- m <-)< P T+CZ ag/mi of CF added to C NBC o0 CF BAg) gobterial ~~Strais ~~~~ > > 500 > 500 > 500 > 500 > 500 J L N I 0 P T+CF ag/m"ifcz ag/mietfcf ts NBCofaCZ > > > 500 'NBCoCf > > >500 >500 ag/ mi) Bacterial N N oterial Strain 0 P Strain K L 0 P FIG. 4. Effect of cephalothin (CF) and cefazolin (CZ) on the MBC of gentamicin (G) and tobramycin (T) against Proteus. The left bar of each pair indicates the MBC of tobramycin or gentamicin in the absence of added cephalosporin. The right bar shows the MBC of the aminoglycoside in the presence of one-fourth or less of the MBC of either cephalothin or cefazolin. ag/m
6 576 HYAMS, SIMBERKOFF, AND RAHAL ANTIMICROB. AG. CHEMOTHER. I TABLE 1. Percent of tested combinations of cephalosporin plus aminoglycoside which produce synergy against Providencia and Proteus Genus tested Tests producing synergy p Tests producing synergy with 62 pg or less of cephalosporin per ml P Providencia 91 (89)a 83 (36) >0.1 ( <0.05)b 0.05 (>0.1)b Proteus 75 (63) 60 (37) a Refers to the percent of tested combinations producing synergy as determined by changes in MIC. Numbers in parenthesis indicate percent of synergy as determined by changes in MBC. bp values were determined by the chi-square test. TABLE 2. Percent of tested combinations of cephalosporin plus aminoglycoside which produce synergy against Providencia and Proteus Tests producing Tests synergy producing synergy with 62 pg/ml or Antibiotic.int p i nless of cephalosporin combination Antibiotic inclu de in Cephalothin 975 (73) >0.05 ( >0.1)" 64 (27) >0.05 (>0.1) Cephazlotin 93 ( (>1) 86 (47) Gentamicin 834(86) >0.1(>0.1) 712(39) >0.1(>0.1) a Refers to the percent of tested combinations producing synergy as determined by changes in MIC. Numbers in parentheses indicate percent producing synergy as determined by changes in MBC. P p values were determined by the chi-square test. quite sensitive to tobramycin despite moderate to high gentamicin resistance. It is possible that gentamicin resistance in these strains is mediated by an acetylating enzyme which does not utilize tobramycin (2). The phenomenbn of cephalosporin-aminoglycoside synergy against Providencia and Proteus is consistent with previous findings of synergy between inhibitors of cell wall metabolism, e.g., penicillins or cephalosporins, and aminoglycosides. Klastersky et al. have recently shown synergy between cephalothin and gentamicin or tobramycin against gentamicinresistant Providencia (11). Our findings confirm their results and further define the bacteriostatic and bactericidal activity of this combination. In addition, the present data suggest that cefazolin may be more effective than cephalothin in producing synergy with aminoglycosides. Recent reports have suggested that the combination of cephalothin and gentamicin is potentially more nephrotoxic than either drug alone (1, 7, 8, 13). Since cefazolin has shown somewhat greater nephrotoxic potential than cephalothin in experimental studies (16), renal function should be carefully monitored during the administration of any cephalosporin-aminoglycoside combination. ACKNOWLEDGMENTS This study was supported by a grant from Eli Lilly and Co. We thank Martha Kuepper for valuable technical assistance. LITERATURE CITED 1. Bobrow, S. N., E. Jaffe, and R. C. Young Anuria and acute tubular necrosis associated with gentamicin and cephalothin. J. Amer. Med. Ass. 222: Brzezinska, M., R. Benveniste, J. Davies, P. J. L. Daniels, and J. Weinstein Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the doexystreptamine moiety. Biochemistry 11: Bulger, R. J In vitro effectiveness of kanamycin and kanamycin/cephalothin against Klebsiella. Amer. Intern. Med. 67: Bulger, R. J., and U. Roosen-Runge Bactericidal activity of the ampicillin/kanamycin combination against Escherichia coli, Enterobacter-Klebsiella and Proteus. Amer. J. Med. Sci. 258: Curreri, P. W., H. M. Bruck, R. B. Lindberg, A. D. Mason, Jr., and B. A. Pruitt, Jr Providencia stuartii sepsie: a new challenge in the treatment of thermal injury. Ann. Surg. 177: Eickhoff, T. C In vitro effect of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa. Appl. Microiol. 18: Fillastre, J. P., R. Laumonier, G. Humbert, D. Dubois, J. Metayer, A. Delpech, J. Leroy, and M. Robert Acute renal failure associated with combined gentamicin and cephalothin therapy. Brit. Med. J. 2: Hansten, P. D Cephalothin, gentamicin, colistin
7 VOL. 5, 1974 CEPHALOSPORIN-AMINOGLYCOSIDE SYNERGY 577 hazards. J. Amer. Med. Ass. 223: Hyams, P. J., M. S. Simberkoff, and J. J. Rahal, Jr In vitro bactericidal effectiveness of four aminoglycoside antibiotics. Antimicrob. Ag. Chemother. 3: Klastersky, J., R. Cappel, G. Swings, and L. Vandenborre Bacteriological and clinical activity of the ampicillin/gentamicin and cephalothin/gentamicin combinations. Amer. J. Med. Sci. 262: Klastersky, J., A. Henri, and L. Vandenborre Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin. Amer. J. Med. Sci. 266: Klastersky, J., G. Swings, and D. Daneau Antimicrobial activity of the carbenicillin/gentamicin combination against gram-negative bacilli. Amer. J. Med. Sci. 260: Kleinknecht, D., D. Ganeval, and D. Droz Acute renal failure after high doses of gentamicin and cephalothin. Lancet 1: Milstoc, M., and P. Steinberg Fatal septicemia due to Providence group bacilli. J. Amer. Geriat. Soc. 21: Morris, A. H Nebulizer contamination in a burn unit. Amer. Rev. Resp. Dis. 107: Silverblatt, F., W. 0. Harrison, and M. Turck Nephrotoxicity of cephalosporin antibiotics in experimental animals. J. Infect. Dis. 128:S367-S Sonne, M., and E. Jawetz Combined action of carbenicillin and gentamicin on Pseudomonas aeruginosa in vitro. Appl. Microbiol. 17:
Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae
ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Oct. 1976, P. 592-597 Copyright 1976 American Society for Microbiology Vol. 1, No. 4 Printed in U.S.A. Comparative Activity of Netilmicin, Gentamicin, Amikacin, and
More informationavailable. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory
ANTimICROBIAL AGENTh AND CHEMOTHERAPY, OCt. 1976, p. 677-681 Copyright 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. In Vitro Susceptibility of Gentamicin-Resistant Enterobacteriaceae
More informationIn Vitro Activity of Netilmicin, Gentamicin, and Amikacin
ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin
More informationUniversity, New York, New York Received for publication 7 May was measured by the broth dilution method as previously
ANTmIcaoBIAL AGuNTS AND CHUMTrHURAPY, Sept. 1976, p. 526-534 Copyright C 1976 American Society for Microbiology Vol. 10, No. 3 Printed in U.S.A. In Vitro Study of Netilmicin Compared with Other Aminoglycosides
More informationAntibiotic Susceptibility of Pseudomonas aeruginosa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1978, p. 979-984 0066-4804/78/0013-0979$02.00/0 Copyright ) 1978 American Society for Microbiology Vol. 13, No. 6 Printed in U.S.A. Effect of Triethylenetetramine
More informationAminoglycoside-resistant enterococci
Aminoglycoside-resistant enterococci M. J. BASKER, B. SLOCOMBE, AND R. SUTHERLAND From Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey J. clin. Path., 1977, 30, 375-380 SUMMARY
More informationDiscrepancy Between Carbenicillin and Ampicillin Activities Against Enterococci and Listeria
ANTMCROBAL AGENTS AND CHEMOTHEAPY, Mar. 193, p. 3339 Copyright 193 American Society for Microbiology Vol. 3, No. 3 Printed in U.S.A. Discrepancy Between Carbenicillin and Ampicillin Activities Against
More informationActivity of Three Aminoglycosides and Two Penicillins Against
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1975, P. 172-178 Copyright @ 1975 American Society for Microbiology Vol. 7, No. 2 Printed in U.S.A. Activity of Three Aminoglycosides and Two Penicillins Against
More informationAntibiotics in Gram-Negative Infections
ANTIMICOBIAL AGENTS AND CHEMOTHEAPY, Dec. 1972, p. 470-475 Copyright 1972 American Society for Microbiology Vol. 2, No. 6 Printed in U.S.A. Clinical Significance of In Vitro Synergism Between Antibiotics
More informationPharmacological Evaluation of Amikacin in Neonates
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.
More informationDisk Susceptibility Studies with Cefazolin and Cephalothin
ANTIMICROBiAL AGENTS AND CHEMOTHEMRAPY, Jan. 1974, p. 63-67 Copyright i 1974 American Society for Microbiology Vol. 5, No. 1 Printed in U.SA. Disk Susceptibility Studies with Cefazolin and Cephalothin
More informationEmergence of Gentamicin- and Carbenicillin-Resistant Pseudomonas aeruginosa in a Hospital Environment
ANTImICROBsuL AGENTS AND CHEMOTHERAPY, Mar. 1976, p. 474-48 Copyright 1976 American Society for Microbiology Vol. 9, No. 3 Printed in U.S.A. Emergence of Gentamicin- and Carbenicillin-Resistant Pseudomonas
More informationVOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill
VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559 ANTIBIOTIC 6640.* Ill BIOLOGICAL STUDIES WITH ANTIBIOTIC 6640, A NEW BROAD-SPECTRUM AMINOGLYCOSIDE ANTIBIOTIC J. Allan Waitz, Eugene L. Moss, Jr., Edwin
More informationTobramycin. Received for publication 5 December 1974
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUIY 75, P. -29 Copyright 75 American Society for Microbiology Vol. 8, No. 1 Printed in U.S.A. Therapy of Pseudomonas aeruginosa Infections with Tobramycin DONALD
More informationEvaluation of the BIOGRAM Antimicrobial Susceptibility Test System
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility
More informationMechanism of Chloramphenicol-Cephaloridine Synergism on Enterobacteriaceae
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1975, p. 845-849 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 6 Printed in U.S.A. Mechanism of -Cephaloridine Synergism on Enterobacteriaceae
More informationComparison of Sisomicin and Gentamicin in Bacteriuric
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1975, p. 742-747 Copyright @ 1975 American Society for Microbiology Vol. 7, No. 6 Printed in U.S.A. Comparison of Sisomicin and Gentamicin in Bacteriuric Patients
More informationIJBCP International Journal of Basic & Clinical Pharmacology
Print ISSN 2319-2003 Online ISSN 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology doi: 10.5455/2319-2003.ijbcp20150405 Research Article Study of renal parameter changes by intraperitoneal
More informationEvaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli
JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1987, p. 546-550 0095-1137/87/030546-05$02.00/0 Copyright C 1987, American Society for Microbiology Vol. 25, No. 3 Evaluation of the AutoMicrobic System for Susceptibility
More informationDrug resistance in relation to use of silver sulphadiazine cream in a burns unit
J. clin. Path., 1977, 30, 160-164 Drug resistance in relation to use of silver sulphadiazine cream in a burns unit KIM BRIDGES AND E. J. L. LOWBURY From the MRC Industrial Injuries and Burns Unit, Birmingham
More informationSusceptibility of Staphylococcus aureus to
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1973, p. 263-269 Copyright 0 1973 American Society for Microbiology Vol. 4, No. 3 Printed in U.S.A. Effect of Temperature on the In Vitro Susceptibility of
More informationReassessment of the "Class" Concept of Disk Susceptibility Testing
Reassessment of the "Class" Concept of Disk Susceptibility Testing Disks versus Minimal Inhibitory Concentrations with Eleven Cephalosporins ARTHUR L. BARRY, PH.D., CLYDE THORNSBERRY, PH.D., RONALD N.
More informationIn Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone
More informationBACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)
BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) VA Palo Alto Health Care System April 14, 2017 Trisha Nakasone, PharmD, Pharmacy Service Russell Ryono, PharmD, Public Health Surveillance
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationTreatment of Gram-negative infections in patients before and after
Postgrad. med. J. (April 1969) 45, 254-260. Treatment of Gram-negative infections in patients before and after renal transplantation Summary Sixty-six Gram-negative infections, occurring in thirty-four
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More informationof Staphylococcus aureus
APPLIED MICROBTOLOGY, Dec. 97, p. -7 Copyright ( 97 American Society for Microbiology Vol., No. 6. Printed in U.S.A. Bacteriophage Types and Antibiotic Susceptibility of Staphylococcus aureus J. KLASTERSKY,
More informationAntimicrobial Susceptibility in Gram-Negative Bacteremia: Are
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1989, p. 1855-1859 0066-4804/89/111855-05$02.00/0 Copyright 1989, American Society for Microbiology Vol. 33, No. 11 Antimicrobial Susceptibility in Gram-Negative
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More informationStaphylococcus aureus
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, OCt. 1981, p. 463-469 0066-4804/81/100463-07$02.00/0 Vol. 20, No. 4 In Vitro and In Vivo Studies of Three Antibiotic Combinations Against Gram-Negative Bacteria and
More informationClinical and Bacteriological Evaluation of Netilmicin in Gram-Negative Infections
ANTrxcRoBAL AG rnts AND CHEMOTHERAPY, OCt. 1977, p. 53-59 Copyright 1977 American Society for Microbiology Vol. 12, No. 4 Printed in U.S.A. Clinical and Bacteriological Evaluation of Netilmicin in Gram-Negative
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationConcise Antibiogram Toolkit Background
Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions
More informationcoverage. The purpose of this study was to compare the susceptibility of 297 strains of anaerobic and a new broad-spectrum semisynthetic
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1978, p. 643-649 0066-4804/78/0014-0643$02.00/0 Copyright 1978 American Society for Microbiology Vol. 14, No. 5 Printed in U.S.A. Susceptibility of the Anaerobic
More informationAn evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",
More informationIn Vitro Susceptibility of Brucella
APPuED MICROBIOLOGY, Oct. 1970, p. 600-604 Vol. 20, No. 4 Copyright 1970 American Society for Microbiology Printed in U.S.A. In Vitro Susceptibility of Brucella to Various Antibiotics WENDELL H. HALL AND
More informationEffeet on Bacterial Growth
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 17, p. 36-366 Copyright ( 17 American Society for Microbiology Vol., No. 5 Printed in U.S.A. Automatic Radiometric Measurement of Antibiotic Effeet on Bacterial
More informationProtein Synthesis Inhibitors
Protein Synthesis Inhibitors Assistant Professor Dr. Naza M. Ali 11 Nov 2018 Lec 7 Aminoglycosides Are structurally related two amino sugars attached by glycosidic linkages. They are bactericidal Inhibitors
More informationQuality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck
Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck DONNA J. BLAZEVIC, M.P.H., MARILYN H. KOEPCKE, B.S., A JOHN M. MATSEN, M.D. Departments of Laboratory Medicine
More informationAminoglycoside Antibiotics Against Cephalothin-Resistant
A?TMCROBAL AGENTS AND CHEMOTHERAPY, May 1976, P. 780-786 Copyright 1976 American Society for Microbiology Vol. 9, No. 5 Printed in U.S.A. Antibacterial Activity of Selected Beta-Lactam and Aminoglycoside
More informationRETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR
Original article RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR R.Sujatha 1,Nidhi Pal 2, Deepak S 3 1. Professor & Head, Department
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationExperimental Pseudomonas Bacteremia in Neutropenic Rats
ANTIMICROBIAL AGENTs AND CHZMOTHERAPY, OCt. 1976, p. 646-651 Copyright C) 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. Synergistic Activity of Carbenicillin and Gentamicin in
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationSusceptibility and Synergy Studies of Methicillin-Resistant Staphylococcus epidermidis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1979, p. 655-659 0066-4804/79/11-0655/05$02.00/0 Vol. 16, No. 5 Susceptibility and Synergy Studies of Methicillin-Resistant Staphylococcus epidermidis MICHAEL
More informationR-factor mediated trimethoprim resistance: result of two three-month clinical surveys
Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department
More informationAntimicrobial Pharmacodynamics
Antimicrobial Pharmacodynamics November 28, 2007 George P. Allen, Pharm.D. Assistant Professor, Pharmacy Practice OSU College of Pharmacy at OHSU Objectives Become familiar with PD parameters what they
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationFig. 1. Bactericidal effect of guinea-pig complement against E. coil NIHJ JC-2, P. aeruginosa 18 S and S. aureus 209 P
Fig. 1. Bactericidal effect of guinea-pig complement against E. coil NIHJ JC-2, P. aeruginosa 18 S and S. aureus 209 P Table 1. IDsos of the test antibiotics against each strain of bacterium Fig. 2. Synergy
More informationBactericidal and Bacteriostatic Action of Chloramphenicol
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUly 1979, p. 13-18 66-484/79/7-13/6$2./ Vol. 16, No. 1 Bactericidal and Bacteriostatic Action of Chloramphenicol Against Meningeal Pathogens JAMES J. RAHAL, JR.,'*
More informationLab Exercise: Antibiotics- Evaluation using Kirby Bauer method.
Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.
More informationDetermination of antibiotic sensitivities by the
Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,
More informationSynergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci
Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious
More informationOutline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010
Multi-Drug Resistant Organisms Is Combination Therapy the Way to Go? Sutthiporn Pattharachayakul, PharmD Prince of Songkhla University, Thailand Outline Prevalence of anti-microbial resistance in Acinetobacter
More informationAntimicrobials & Resistance
Antimicrobials & Resistance History 1908, Paul Ehrlich - Arsenic compound Arsphenamine 1929, Alexander Fleming - Discovery of Penicillin 1935, Gerhard Domag - Discovery of the red dye Prontosil (sulfonamide)
More informationLactose-Fermenting Bacteria Isolated from
APPuE MICROBIOLOGY, Nov. 969, p. 98-94 VoL 8, No. 5 Copyright 969 American Society for Microbiology Printed in U.S.A. Incidence of Infectious Drug Resistance Among Lactose-Fermenting Bacteria Isolated
More informationAntibiotic-resistant Staphylococcus aureus in dermatology and burn wards
J. clin. Path., 1977, 30, 40-44 Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards G. A. J. AYLIFFE, WENDA GREEN, R. LIVINGSTON, AND E. J. L. LOWBURY From the Hospital Infection Research
More informationTitle: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic
AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationReceived 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More information4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases
4 th and 5 th generation cephalosporins Naderi HR Associate professor of Infectious Diseases Classification Forth generation: Cefclidine, cefepime (Maxipime),cefluprenam, cefoselis,cefozopran, cefpirome
More informationComparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys
ANTIbMCROBIAL AGENTS AND CHEMOTHERAPY, June 197, p. 460-465 Copyright 197 American Society for Microbiology Vol. 1, No. 6 Printed in U.S.A. Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal
More informationIn Vitro Activity of Piperacillin, a New Semisynthetic Penicillin with an Unusually Broad Spectrum of Activity
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, March 1978, p. 349-357 66-484/8/133-349$2./ Copyright 1978 American Society for Microbiology Vol. 13, No. 3 Printed in U.S.A. In Vitro Activity of Piperacillin, a
More informationStudies on Antibiotic Synergism Against Enterococci
Studies on Antibiotic Synergism Against Enterococci II. EFFECT OF VARIOUS ANTIBIOTICS ON THE UPTAKE OF 4C-LABELED STREPTOMYCIN BY ENTEROCOCCI ROBERT C. MOELLERING, JR. and ARNOLD N. WEINBERG From the Infectious
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationIntroduction to Pharmacokinetics and Pharmacodynamics
Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:
More informationAntibiotics & Resistance
What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationPrinciples of Antimicrobial Therapy
Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1
More informationOther than Pseudomonas aeruginosa Recovered
ANTIMICOBIAL AGENT AND CHEMOTHEAPY, Nov. 1972, p. 344-349 Copyright 1972 American ociety for Microbiology Vol. 2, No. 5 Printed in U..A. In Vitro Antibiotic usceptibility of Pseudomonads Other than Pseudomonas
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationOther β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL
Other β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL David P. Nicolau, PharmD, FCCP, FIDSA Director, Center for Anti-Infective Research and Development Hartford Hospital
More informationASPECTS OF IN VITRO SYNERGISM, REGISTERED IN ANIMALS
ANALELE UNIVERSITATII DIN ORADEA, Fascicula Ecotoxicologie, Zootehnie si Tehnologii de Industrie Alimentara ASPECTS OF IN VITRO SYNERGISM, REGISTERED IN ANIMALS Chereji Anca*, Chereji R.**, Cernea M.*,
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationCARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE)
CARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE) Bartsch SM et al. Potential economic burden of carbapenem-resistent Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect 2017;23(1):48e9-e16.
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More information2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital
2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....
More informationAntimicrobial susceptibility
Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL
More informationFactors affecting plate assay of gentamicin
Journal of Antimicrobial Chemotherapy (1977) 3, 17-23 Factors affecting plate assay of gentamicin II. Media D. C. Shanson* and C. J. Hince Department of Medical Microbiology, The London Hospital Medical
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationStaphylococcus aureus with the Disc
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1972, p. 422-426 Vol. 1, No. 5 Copyright 1972 American Society for Microbiology Printed in U.S.A. Identification of Cephalosporin-Resistant Staphylococcus aureus
More informationNew Method for Antibiotic Susceptibility Testing
ANTIMIROBIAL AGENTS AND HEMOTHERAPY, Aug. 1972, p. 51-56 opyright 1972 American Society for Microbiology Vol. 2, No. 2 Printed in U.S.A. New Method for Antibiotic Susceptibility Testing G. N. ROLINSON
More informationPrevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia
Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia Ruta Paberza 1, Solvita Selderiņa 1, Sandra Leja 1, Jelena Storoženko 1, Lilija Lužbinska 1, Aija Žileviča 2*
More informationAntimicrobials. Antimicrobials
Antimicrobials For more than 50 years, antibiotics have come to the rescue by routinely producing rapid and long-lasting miracle cures. However, from the beginning antibiotics have selected for resistance
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationCF WELL Pharmacology: Microbiology & Antibiotics
CF WELL Pharmacology: Microbiology & Antibiotics Bradley E. McCrory, PharmD, BCPS Clinical Pharmacy Specialist Pulmonary Medicine Cincinnati Children s Hospital Medical Center January 26, 2017 Disclosure
More informationMercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016
Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationSelective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016
Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationComparison of antibiotic susceptibility results obtained with Adatab* and disc methods
J Clin Pathol 1984;37:159-165 Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods JJS SNELL, MVS DANVERS, PS GARDNER From the Division of Microbiological Reagents and
More informationGENTAMICIN: ACTIVITY IN VITRO AGAINST GRAMNEGATIVE ORGANISMS AND CLINICAL EXPERIENCES IN THE TREATMENT OF URINARY TRACT INFECTIONS
390 CHEMOTHERAPY JULY 1967 GENTAMICIN: ACTIVITY IN VITRO AGAINST GRAMNEGATIVE ORGANISMS AND CLINICAL EXPERIENCES IN THE TREATMENT OF URINARY TRACT INFECTIONS M. OHOKOSHI*, Y. NAIDE, T. KAWAMURA, K. SUZUKI,
More information